Noncovalent PEGylation, An Innovative Subchapter in the Field of Protein Modification
Authors:
- 1 February 2016
- journal article
- review article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 105 (2) , 386-390
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Noncovalent PEGylation: Different Effects of Dansyl-, l-Tryptophan–, Phenylbutylamino-, Benzyl- and Cholesteryl-PEGs on the Aggregation of Salmon Calcitonin and LysozymeJournal of Pharmaceutical Sciences, 2012
- Noncovalent PEGylation by Polyanion Complexation as a Means To Stabilize Keratinocyte Growth Factor-2 (KGF-2)Biomacromolecules, 2011
- The freezing step in lyophilization: Physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticalsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Releasable PEGylation of proteins with customized linkersAdvanced Drug Delivery Reviews, 2008
- Protein therapeutics: a summary and pharmacological classificationNature Reviews Drug Discovery, 2008
- Effects of protein aggregates: An immunologic perspectiveThe AAPS Journal, 2006
- Pharmacokinetic Consequences of PegylationDrug Delivery, 2006
- Prolonging the Action of Protein and Peptide Drugs by a Novel Approach of Reversible Polyethylene Glycol ModificationJournal of Biological Chemistry, 2004
- Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugatesAdvanced Drug Delivery Reviews, 2003
- Controlled Release of Proteins from Their Poly(Ethylene Glycol) Conjugates: Drug Delivery Systems Employing 1,6-EliminationBioconjugate Chemistry, 2003